CY1121362T1 - Παραγωγα της 1,2-διϋδρο-3η- πυρρολo[1,2-c] ιμιδαζολ-3-ονης και η χρηση τους ως αντιβακτηριακοι παραγοντες - Google Patents

Παραγωγα της 1,2-διϋδρο-3η- πυρρολo[1,2-c] ιμιδαζολ-3-ονης και η χρηση τους ως αντιβακτηριακοι παραγοντες

Info

Publication number
CY1121362T1
CY1121362T1 CY20191100131T CY191100131T CY1121362T1 CY 1121362 T1 CY1121362 T1 CY 1121362T1 CY 20191100131 T CY20191100131 T CY 20191100131T CY 191100131 T CY191100131 T CY 191100131T CY 1121362 T1 CY1121362 T1 CY 1121362T1
Authority
CY
Cyprus
Prior art keywords
pyrrol
producers
imidazol
dihydro
antibacterial agents
Prior art date
Application number
CY20191100131T
Other languages
Greek (el)
English (en)
Inventor
Gaelle CHAPOUX
Jean-Christophe Gauvin
Philippe Panchaud
Jean-Luc Specklin
Jean-Philippe Surivet
Christine Schmitt
Azely MIRRE
Original Assignee
Idorsia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idorsia Pharmaceuticals Ltd filed Critical Idorsia Pharmaceuticals Ltd
Publication of CY1121362T1 publication Critical patent/CY1121362T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41881,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
CY20191100131T 2014-03-04 2019-01-30 Παραγωγα της 1,2-διϋδρο-3η- πυρρολo[1,2-c] ιμιδαζολ-3-ονης και η χρηση τους ως αντιβακτηριακοι παραγοντες CY1121362T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14157636 2014-03-04
PCT/EP2015/054358 WO2015132228A1 (en) 2014-03-04 2015-03-03 1,2-dihydro-3h-pyrrolo[1,2-c]imidazol-3-one derivatives and their use as antibacterial agents

Publications (1)

Publication Number Publication Date
CY1121362T1 true CY1121362T1 (el) 2020-05-29

Family

ID=50189621

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20191100131T CY1121362T1 (el) 2014-03-04 2019-01-30 Παραγωγα της 1,2-διϋδρο-3η- πυρρολo[1,2-c] ιμιδαζολ-3-ονης και η χρηση τους ως αντιβακτηριακοι παραγοντες

Country Status (31)

Country Link
US (1) US10106544B2 (enExample)
EP (1) EP3114126B1 (enExample)
JP (1) JP6516370B2 (enExample)
KR (1) KR20160127127A (enExample)
CN (1) CN106061977B (enExample)
AR (1) AR099612A1 (enExample)
AU (1) AU2015226250B2 (enExample)
BR (1) BR112016020278A8 (enExample)
CA (1) CA2938383A1 (enExample)
CL (1) CL2016002207A1 (enExample)
CY (1) CY1121362T1 (enExample)
DK (1) DK3114126T3 (enExample)
EA (1) EA030708B1 (enExample)
ES (1) ES2709382T3 (enExample)
HR (1) HRP20190013T1 (enExample)
HU (1) HUE042371T2 (enExample)
IL (1) IL247544A0 (enExample)
LT (1) LT3114126T (enExample)
MA (1) MA39707B1 (enExample)
MX (1) MX2016011380A (enExample)
PH (1) PH12016501699A1 (enExample)
PL (1) PL3114126T3 (enExample)
PT (1) PT3114126T (enExample)
SA (1) SA516371717B1 (enExample)
SG (1) SG11201607304WA (enExample)
SI (1) SI3114126T1 (enExample)
TR (1) TR201900393T4 (enExample)
TW (1) TW201542556A (enExample)
UA (1) UA118868C2 (enExample)
WO (1) WO2015132228A1 (enExample)
ZA (1) ZA201606794B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR097617A1 (es) 2013-09-13 2016-04-06 Actelion Pharmaceuticals Ltd Derivados antibacterianos del 2h-indazol
TR201807881T4 (tr) 2013-12-19 2018-06-21 Idorsia Pharmaceuticals Ltd Antibakteriyel 1h-ındazol ve 1h-ındol türevleri.
JP2017515906A (ja) 2014-05-16 2017-06-15 アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd 抗菌性キナゾロン−4(3h)−オン誘導体
AR105646A1 (es) * 2015-08-11 2017-10-25 Actelion Pharmaceuticals Ltd Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida
US20190031676A1 (en) * 2015-08-28 2019-01-31 Idorsia Pharmaceuticals Ltd Antibacterial annulated pyrrolidin-2-one derivatives
AR105848A1 (es) * 2015-08-31 2017-11-15 Actelion Pharmaceuticals Ltd Derivados heterocíclicos antibacterianos
AR105889A1 (es) * 2015-09-03 2017-11-22 Actelion Pharmaceuticals Ltd Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos
TW201840569A (zh) 2017-03-01 2018-11-16 瑞士商愛杜西亞製藥有限公司 (2r)-n-羥基-4-(6-((1-(2-羥基乙基)氮雜環丁烷-3-基)丁-1,3-二炔-1-基)-3-氧基-1h-吡咯并[1,2-c]咪唑-2(3h)-基)-2-甲基-2-(甲磺醯基)丁醯胺之結晶形式
WO2019038362A1 (en) 2017-08-24 2019-02-28 Idorsia Pharmaceuticals Ltd ANTIBACTERIAL PYRROLOIMIDAZOLONES
WO2019086452A1 (en) 2017-10-31 2019-05-09 Idorsia Pharmaceuticals Ltd Antibacterial heteroaromatic compounds
EP4382527A4 (en) * 2021-08-05 2025-08-20 Zhejiang Hisun Pharm Co Ltd AROMATIC ACETYLENE DERIVATIVE, PROCESS FOR ITS PREPARATION AND USE

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2478374C (en) 2002-03-13 2009-01-06 Eli M. Wallace N3 alkylated benzimidazole derivatives as mek inhibitors
US7781591B2 (en) 2006-06-13 2010-08-24 Wyeth Llc Substituted 3-cyanopyridines as protein kinase inhibitors
DE102004017930A1 (de) 2004-04-14 2005-11-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
CN101115725A (zh) 2004-12-10 2008-01-30 埃莫里大学 治疗病毒感染和异常细胞增殖的2’和3’-取代的环丁基核苷类似物
JP2008001635A (ja) 2006-06-22 2008-01-10 Toray Ind Inc グリシン誘導体及びその用途
DE102008044132A1 (de) 2008-11-27 2010-06-02 BSH Bosch und Siemens Hausgeräte GmbH Kältegerät mit zweiseitig anschlagbarer Tür
KR20120006016A (ko) 2009-04-06 2012-01-17 다이이찌 산쿄 가부시키가이샤 치환 페닐기를 갖는 고리형 화합물
EP2432468A2 (en) 2009-05-20 2012-03-28 Ardea Biosciences, Inc. Methods of modulating uric acid levels
WO2011021209A1 (en) 2009-07-07 2011-02-24 Portsmouth Technologies Llc Histone deacetylase inhibitors
CA2774250C (en) * 2009-10-13 2013-12-17 Pfizer Inc. C-linked hydroxamic acid derivatives useful as antibacterial agents
PL2512474T3 (pl) 2009-12-16 2015-03-31 Pfizer N-przyłączone pochodne kwasu hydroksamowego użyteczne jako środki przeciwbakteryjne
MX2013005200A (es) 2010-11-10 2013-06-28 Achaogen Inc Derivados de acido hidroxamico y su so en el tratamiento de infecciones bacterianas.
JP2014501274A (ja) 2011-01-03 2014-01-20 ハンミ ファーム. シーオー., エルティーディー. Gタンパク質共役受容体調節のための新規な二環式化合物
AP3336A (en) * 2011-03-07 2015-07-31 Pfizer Fluoro-pyridinone derivatives useful as antibacterial agents
SG193458A1 (en) * 2011-04-08 2013-10-30 Pfizer Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
CN103717582B (zh) * 2011-04-08 2015-09-30 辉瑞大药厂 用作抗菌剂的异*唑衍生物
US8859559B2 (en) 2011-12-20 2014-10-14 Boehringer Ingelheim International Gmbh Substituted pyrazines and their use in the treatment of disease
WO2013170030A1 (en) 2012-05-09 2013-11-14 Achaogen, Inc. Antibacterial agents
WO2013170165A1 (en) * 2012-05-10 2013-11-14 Achaogen, Inc. Antibacterial agents
WO2014165075A1 (en) 2013-03-12 2014-10-09 Achaogen, Inc. Antibacterial agents
AR097617A1 (es) 2013-09-13 2016-04-06 Actelion Pharmaceuticals Ltd Derivados antibacterianos del 2h-indazol
TR201807881T4 (tr) 2013-12-19 2018-06-21 Idorsia Pharmaceuticals Ltd Antibakteriyel 1h-ındazol ve 1h-ındol türevleri.
JP2017515906A (ja) 2014-05-16 2017-06-15 アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd 抗菌性キナゾロン−4(3h)−オン誘導体
AR105646A1 (es) 2015-08-11 2017-10-25 Actelion Pharmaceuticals Ltd Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida
US20190031676A1 (en) 2015-08-28 2019-01-31 Idorsia Pharmaceuticals Ltd Antibacterial annulated pyrrolidin-2-one derivatives
AR105848A1 (es) 2015-08-31 2017-11-15 Actelion Pharmaceuticals Ltd Derivados heterocíclicos antibacterianos
AR105889A1 (es) 2015-09-03 2017-11-22 Actelion Pharmaceuticals Ltd Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos
RU2018124788A (ru) 2015-12-08 2020-01-15 Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед Замещенные бензазиноны в качестве антибактериальных соединений

Also Published As

Publication number Publication date
LT3114126T (lt) 2018-12-27
TR201900393T4 (tr) 2019-02-21
US20170107223A1 (en) 2017-04-20
MX2016011380A (es) 2016-12-07
US10106544B2 (en) 2018-10-23
BR112016020278A2 (enExample) 2017-08-15
JP6516370B2 (ja) 2019-05-22
SG11201607304WA (en) 2016-09-29
EA030708B1 (ru) 2018-09-28
ZA201606794B (en) 2018-11-28
ES2709382T3 (es) 2019-04-16
TW201542556A (zh) 2015-11-16
EP3114126A1 (en) 2017-01-11
IL247544A0 (en) 2016-11-30
AU2015226250A1 (en) 2016-10-20
HUE042371T2 (hu) 2019-06-28
HRP20190013T1 (hr) 2019-02-22
KR20160127127A (ko) 2016-11-02
AU2015226250B2 (en) 2018-12-13
PL3114126T3 (pl) 2019-03-29
CL2016002207A1 (es) 2017-03-24
DK3114126T3 (en) 2019-02-25
AR099612A1 (es) 2016-08-03
JP2017508746A (ja) 2017-03-30
MA39707B1 (fr) 2019-01-31
CA2938383A1 (en) 2015-09-11
CN106061977A (zh) 2016-10-26
EP3114126B1 (en) 2018-10-31
SA516371717B1 (ar) 2018-10-25
EA201691775A1 (ru) 2017-03-31
WO2015132228A1 (en) 2015-09-11
CN106061977B (zh) 2018-10-26
PT3114126T (pt) 2019-02-06
BR112016020278A8 (pt) 2017-12-26
PH12016501699A1 (en) 2016-10-03
UA118868C2 (uk) 2019-03-25
MA39707A (fr) 2017-01-11
SI3114126T1 (sl) 2019-01-31

Similar Documents

Publication Publication Date Title
CY1121362T1 (el) Παραγωγα της 1,2-διϋδρο-3η- πυρρολo[1,2-c] ιμιδαζολ-3-ονης και η χρηση τους ως αντιβακτηριακοι παραγοντες
CY1120111T1 (el) Αντιβακτηριακα παραγωγα 2η-ινδαζολης
CY1122821T1 (el) Παραγωγα 1,3-βενζοδιοξολιου ως αναστολεις εζη1 ή/και εζη2
CY1121901T1 (el) Ενωσεις τριαζολοπυριμιδινης και χρησεις αυτων
CY1120173T1 (el) Ενωση πυραζολο-αμιδιου και φαρμακευτικες χρησεις αυτης
CY1121948T1 (el) Πυρρολο [1,2,f][1,2,4]tpiazineς χρησιμες για θεραπεια λοιμωξεων αναπνευστικου συγκυτιακου ιου
CY1124929T1 (el) 4-οξο-3,4-διυδρο-1,2,3-βενζοτριαζινες ως ρυθμιστες του gpr139
CY1120834T1 (el) Δικυκλικες αζωτουχες ενωσεις ως αγωνιστες μουσκαρινικων υποδοχεων μ1
CY1116192T1 (el) Πυρρολοβενζοδιαζεπινες και συζευγματα αυτων
CR20170573A (es) Lactamas bicíclicas y métodos de uso de las mismas
EA201692219A1 (ru) Способы получения противовирусных соединений
CY1121384T1 (el) Συνδυαστικη θεραπεια για την αγωγη ανθεκτικων βακτηριακων λοιμωξεων
CY1122563T1 (el) ΑΜΙΔΟΫΠΟΚΑΤΕΣΤΗΜΕΝΑ ΘΕΙΑΖΟΛΙΑ ΩΣ ΔΙΑΜΟΡΦΩΤΕΣ RORγt
CY1119583T1 (el) Φαινοξυαιθυλο παραγωγα κυκλικης αμινης και η δραστικοτητα τους ως τροποποιητες του ερ4 υποδοχεα
CY1125285T1 (el) Θεραπεια για τη νοσο του παρκινσον
EA201790627A1 (ru) СТИМУЛЯТОРЫ рГЦ
CY1124479T1 (el) Ενωσεις που περιεχουν υποκατεστημενο αζωτο
CU20170007A7 (es) Compuestos de imidazopiridazina
CY1122971T1 (el) Ενωσεις διυδροπυριμιδιν-2-ονης και ιaτρικη χρηση αυτων
CY1125272T1 (el) Νεα αλατα και πολυμορφα toy scy-078
EA201691412A1 (ru) Гидроксиформамидные производные и их применение
CY1120142T1 (el) Ενωσεις αζετιδινυλοξυφαινυλοπυρρολiδινης
EA201890476A1 (ru) ЗАМЕЩЕННЫЕ 1,2-ДИГИДРО-3H-ПИРРОЛО[1,2-c]ИМИДАЗОЛ-3-ОНЫ В КАЧЕСТВЕ АНТИБАКТЕРИАЛЬНЫХ СРЕДСТВ
CR20190078A (es) Derivado de triazolopirazinona útil como un inhibidor de pde1 humano
PE20170524A1 (es) Dihidropirimidinonas biciclicas sustituidas y su uso como inhibidores de la actividad de elastasa neutrofila